AlphaRose Therapeutics Inc — Form C/A (Regulation Crowdfunding)
AlphaRose Therapeutics Inc of AUSTIN, TX filed a Form C/A (Regulation Crowdfunding) with the SEC on 2025-08-27. Target raise $20K, up to $5.0M. Offered through StartEngine Primary, LLC.
Offering
- Filed: 2025-08-27
- Form: C/A
- Accession: 0001665160-25-001394
- Target amount: $20K
- Maximum amount: $5.0M
- Security type: Common Stock
- Securities offered: 14,814
- Price: $1.3500
- Deadline: 2025-09-29
- Funding portal / intermediary: StartEngine Primary, LLC
- Intermediary file number: 008-70060
Issuer
- CIK: 0002051498
- Website: https://www.alpharose.com/
- Legal status: Corporation
- Organized in: DE
- Incorporated: 2023-10-31
- Address: 1401 LAVACA STREET, #851, AUSTIN, TX, 78701
- Employees: 1
Financials (as filed)
- Total assets (most recent): $614K
- Cash (most recent): $526K
- Net income (most recent): $-625K
- Short-term debt: $81K
- Long-term debt: $1.2M
People (5)
| Name | Role | Location |
|---|
| Masako Nakamura | Board Member | AUSTIN, TX |
| Casey Mcpherson | CEO, Principal Accounting and Financial Officer, and Board Member | AUSTIN, TX |
| Alan Edmund Walts | Board Member | AUSTIN, TX |
| Belinda Ann Termeer | Board Member | AUSTIN, TX |
| Lance Hirsch | Board Member | AUSTIN, TX |
Reg CF filing history (7)
More